Katie Kennedy
Family · Lancaster, PANPI 1245953710
Payments from drug & device makers
Across 128 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$402
- Novo Nordisk$264
- AbbVie$260
- Lilly USA, LLC$233
- Otsuka America Pharmaceutical, Inc.$205
- SK Life Science, Inc.$193
- plus $936 from 22 others
What the payments were for
- Food & beverage$2,493100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $402 |
| Novo Nordisk | 16 | $264 |
| AbbVie | 13 | $260 |
| Lilly USA, LLC | 11 | $233 |
| Otsuka America Pharmaceutical, Inc. | 10 | $205 |
| SK Life Science, Inc. | 9 | $193 |
| Bayer | 7 | $152 |
| Pfizer | 7 | $125 |
| Phathom Pharmaceuticals, Inc. | 4 | $87 |
| Exact Sciences | 3 | $66 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $57 |
| Lundbeck LLC | 2 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $28 |
| Ardelyx, Inc. | 1 | $25 |
| GSK | 1 | $24 |
| Johnson & Johnson | 1 | $24 |
| Neurelis, Inc. | 1 | $23 |
| UCB, Inc. | 1 | $22 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Averitas Pharma Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
How this compares
$2,493 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 400 | $84,239 |
| OzempicSemaglutide | 36 | $37,001 |
| JardianceEmpagliflozin | 60 | $18,301 |
| TrulicityDulaglutide | 17 | $16,847 |
| Tresiba Flextouch U-100Insulin Degludec | 21 | $11,358 |
| RexultiBrexpiprazole | 31 | $11,337 |
| RelistorMethylnaltrexone Bromide | 12 | $10,184 |
| JanuviaSitagliptin Phosphate | 32 | $9,175 |
| XareltoRivaroxaban | 12 | $7,578 |
| Xtampza ErOxycodone Myristate | 16 | $6,346 |
| KonvomepOmeprazole/Sodium Bicarbonate | 15 | $6,285 |
| KerendiaFinerenone | 35 | $5,877 |
| Aripiprazole | 25 | $5,185 |
| Atorvastatin Calcium | 268 | $4,582 |
| MyrbetriqMirabegron | 17 | $3,919 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $125 | $84,239400 claims |
| Novo NordiskOzempic, Levemir | $264 | $39,13254 claims |
| Lilly USA, LLCTrulicity, Olanzapine | $233 | $18,805178 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $205 | $11,33731 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $57 | $10,18412 claims |
| Johnson & JohnsonXarelto | $24 | $7,57812 claims |
| BayerKerendia | $152 | $5,87735 claims |
| Astellas Pharma US IncMyrbetriq | $28 | $3,91917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.
Other family in Lancaster
- Heidi Kling-NewnamLancaster$30K
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.